Healthcare entity
All 1 tracked stories fall under one category: market-trends. Aerogel is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window.
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: market-trends. Aerogel is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. Their average consequence score of 5 runs below the beat's 5.2 for that window. We currently track 1 Healthcare story that mention Anni Seaborne, all published on August 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 40 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Anni Seaborne. Shared-story counts are live from our verified record — not editorial picks.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Source: plymouthherald.co.uk · gazettelive.co.uk
Anni Seaborne is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
